CLINICAL_TRIALS
trial_result
· 2020-07-14
Clinical Trial Update: Empagliflozin and Sympathetic Nerve Traffic [Phase 4]
Summary
Phase 4 clinical trial investigating empagliflozin and sympathetic nerve traffic in type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED